NLRP3 and myocardial infarction: The activation of NLRP3 inflammasome and the release of IL-1β are known to accelerate tissue damage and abnormal remodeling process through NLRP3/TGF-β/Smad pathway in cardiac fibroblasts after myocardial infarction [18,19].